| 1 |
Shusterman E, Kliuk Ben-Bassat O, Zahler D, Kupershmidt A, Weiss-Meilik A, Kehat O, Ablin JN. Risk factors, clinical characteristics and prognostic value of acute kidney injury in COVID-19 compared with influenza virus and respiratory syncytial virus. J Nephrol 2023;:1-11. [PMID: 36971979 DOI: 10.1007/s40620-023-01591-2] [Reference Citation Analysis]
|
| 2 |
Almazmomi MA, Alsieni M. Targeting TLR-4 Signaling to Treat COVID-19-induced Acute Kidney Injury. Journal of Pharmacology and Pharmacotherapeutics 2023. [DOI: 10.1177/0976500x221147798] [Reference Citation Analysis]
|
| 3 |
Mallhi TH, Khan YH, Alzarea AI, Khan FU, Alotaibi NH, Alanazi AS, Butt MH, Alatawi AD, Salman M, Alzarea SI, Almalki ZS, Alghazi MA, Algarni MA. Incidence, risk factors and outcomes of acute kidney injury among COVID-19 patients: A systematic review of systematic reviews. Front Med 2022;9. [DOI: 10.3389/fmed.2022.973030] [Reference Citation Analysis]
|
| 4 |
Sheu RK, Pardeshi MS. A Survey on Medical Explainable AI (XAI): Recent Progress, Explainability Approach, Human Interaction and Scoring System. Sensors (Basel) 2022;22:8068. [PMID: 36298417 DOI: 10.3390/s22208068] [Reference Citation Analysis]
|
| 5 |
Tannor EK, Bajpai D, Nlandu YM, Wijewickrama E. COVID-19 and Kidney Disease: Progress in Health Inequity From Low-Income Settings. Semin Nephrol 2023;42:151318. [PMID: 36796149 DOI: 10.1016/j.semnephrol.2023.151318] [Reference Citation Analysis]
|
| 6 |
Severino P, D'Amato A, Prosperi S, Myftari V, Labbro Francia A, Önkaya M, Notari C, Papisca I, Canuti ES, Yarden Revivo M, Birtolo LI, Celli P, Galardo G, Maestrini V, d'Ettorre G, Mancone M, Fedele F. The Mutual Relationship among Cardiovascular Diseases and COVID-19: Focus on Micronutrients Imbalance. Nutrients 2022;14:3439. [PMID: 36014944 DOI: 10.3390/nu14163439] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Basse P, Morisson L, Barthélémy R, Julian N, Kindermans M, Collet M, Huot B, Gayat E, Mebazaa A, Chousterman BG. Relationship between PEEP levels, central venous pressure, systemic inflammation and AKI in critically ill ventilated COVID-19 patients. A monocenter retrospective study.. [DOI: 10.21203/rs.3.rs-1932903/v1] [Reference Citation Analysis]
|
| 8 |
Tempestilli M, Ascoli Bartoli T, Benvenuto D, Stazi GV, Marchioni L, Nicastri E, Agrati C. Interpatient variability in the pharmacokinetics of remdesivir and its main metabolite GS-441524 in treated COVID-19 subjects. J Antimicrob Chemother 2022:dkac234. [PMID: 35848782 DOI: 10.1093/jac/dkac234] [Reference Citation Analysis]
|
| 9 |
Sharma H, Behera MR, Bhadauria DS, Khushwaha RS, Yachha M, Patel MR, Kaul A, Prasad N. High mortality and residual kidney damage with Coronavirus disease-19-associated acute kidney injury in northern India. Clin Exp Nephrol 2022. [PMID: 35804207 DOI: 10.1007/s10157-022-02247-4] [Reference Citation Analysis]
|
| 10 |
Wong CKH, Au ICH, Cheng WY, Man KKC, Lau KTK, Mak LY, Lui SL, Chung MSH, Xiong X, Lau EHY, Cowling BJ. Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID-19: a self-controlled case series study. Aliment Pharmacol Ther 2022;56:121-30. [PMID: 35318694 DOI: 10.1111/apt.16894] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 11 |
De Rosa S, Marengo M, Romagnoli S, Fiorentino M, Fanelli V, Fiaccadori E, Brienza N, Morabito S, Pota V, Valente F, Grasselli G, Messa P, Giarratano A, Cantaluppi V. Management of Acute Kidney Injury and Extracorporeal Blood Purification Therapies During the COVID-19 Pandemic: The Italian SIN-SIAARTI Joint Survey (and Recommendations for Clinical Practice). Front Med (Lausanne) 2022;9:850535. [PMID: 35463000 DOI: 10.3389/fmed.2022.850535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Sabaghian T, Kharazmi AB, Ansari A, Omidi F, Kazemi SN, Hajikhani B, Vaziri-Harami R, Tajbakhsh A, Omidi S, Haddadi S, Shahidi Bonjar AH, Nasiri MJ, Mirsaeidi M. COVID-19 and Acute Kidney Injury: A Systematic Review. Front Med (Lausanne) 2022;9:705908. [PMID: 35445048 DOI: 10.3389/fmed.2022.705908] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 13 |
Naqvi I, Giroux N, Olson L, Morrison SA, Llanga T, Akinade TO, Zhu Y, Zhong Y, Bose S, Arvai S, Abramson K, Chen L, Que L, Kraft B, Shen X, Lee J, Leong KW, Nair SK, Sullenger B. DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists. Biomaterials 2022;283:121393. [PMID: 35349874 DOI: 10.1016/j.biomaterials.2022.121393] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 14 |
Samaan F, Carneiro de Paula E, de Lima Souza FBG, Mendes LFC, Rossi PRG, Freitas RAP, Nakagawa FT, Maciel AT, Aranha S, Osawa E, Konigsfeld HP, da Silva RG, de Souza RBC, Coutinho SM, Vieira TD, Thomaz KB, Flato EMS, da Silva RC, Andrade LV, Badaoui M, Badaoui EP, Goes MÂ, do Amaral SH, Cunha K, Muniz IM, Sampaio JS, Durão Junior MS, Zanetta DMT, Burdmann EA. COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: A multicenter study in São Paulo, Brazil. PLoS One 2022;17:e0261958. [PMID: 35030179 DOI: 10.1371/journal.pone.0261958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Meshram H, Banerjee S, Dave R, Chauhan S, Kute V, Patel H, Desai S, Tambi P, Shah N, Shah A. COVID-19 associated acute kidney injury in the second wave of pandemic in India: A single-center retrospective report. Saudi Crit Care J 2022;6:7. [DOI: 10.4103/sccj.sccj_32_21] [Reference Citation Analysis]
|
| 16 |
Bjornstad EC, Seifert ME, Sanderson K, Feig DI. Kidney implications of SARS-CoV2 infection in children. Pediatr Nephrol 2022;37:1453-67. [PMID: 34453600 DOI: 10.1007/s00467-021-05249-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 17 |
Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [PMID: 34868898 DOI: 10.5500/wjt.v11.i11.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 18 |
Elgharabawy A, Prasad M, Lin CT. Subgroup Preference Neural Network. Sensors (Basel) 2021;21:6104. [PMID: 34577312 DOI: 10.3390/s21186104] [Reference Citation Analysis]
|
| 19 |
Angamo MT, Mohammed MA, Peterson GM. Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis. Infection 2021. [PMID: 34331674 DOI: 10.1007/s15010-021-01671-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 20 |
Zufferey PJ, Dupont A, Lanoiselée J, Bauters A, Poissy J, Goutay J, Jean L, Caplan M, Levy L, Susen S, Delavenne X. Pharmacokinetics of enoxaparin in COVID-19 critically ill patients. Thromb Res 2021;205:120-7. [PMID: 34311154 DOI: 10.1016/j.thromres.2021.07.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 21 |
Battaglini D, Robba C, Fedele A, Trancǎ S, Sukkar SG, Di Pilato V, Bassetti M, Giacobbe DR, Vena A, Patroniti N, Ball L, Brunetti I, Torres Martí A, Rocco PRM, Pelosi P. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome. Front Med (Lausanne) 2021;8:671714. [PMID: 34150807 DOI: 10.3389/fmed.2021.671714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 22 |
Miranda MZ, Lichner Z, Szászi K, Kapus A. MRTF: Basic Biology and Role in Kidney Disease. Int J Mol Sci 2021;22:6040. [PMID: 34204945 DOI: 10.3390/ijms22116040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 23 |
Noori M, Nejadghaderi SA, Sullman MJM, Carson-Chahhoud K, Kolahi AA, Safiri S. Epidemiology, prognosis and management of potassium disorders in Covid-19. Rev Med Virol 2021;:e2262. [PMID: 34077995 DOI: 10.1002/rmv.2262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 24 |
Enikeev D, Taratkin M, Efetov S, Shlomina A, Boldyreva M, Galkina I, Spivak L, Gitel E, Kuchieva A, Mikhailov V, Teoh JY, Herrmann TRW, Kikic Ž, Fomin V, Shariat SF, Glybochko P. Acute kidney injury in COVID-19: are kidneys the target or just collateral damage? A comprehensive assessment of viral RNA and AKI rate in patients with COVID-19. Curr Opin Urol 2021;31:363-8. [PMID: 33989230 DOI: 10.1097/MOU.0000000000000901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 25 |
Yaseen MO, Yaseen M, Khan TM, Jamshaid H, Naveed HMA, Imran MS. A Systematic Review of Systematic Reviews on the Incidence of Acute Kidney Injury in COVID-19 Patients. Pharmacophore 2021;12:92-102. [DOI: 10.51847/pd4wbgnnfm] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 26 |
Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, Cantaluppi V. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 2021;17:751-64. [PMID: 34226718 DOI: 10.1038/s41581-021-00452-0] [Cited by in Crossref: 150] [Cited by in F6Publishing: 151] [Article Influence: 75.0] [Reference Citation Analysis]
|
